Cell biological and physicochemical aspects of arterial calcification

Kidney International

Volumn 79, Issue 11, 2011, Pages 1166-1177

  Neven, Ellen ^a   De Schutter, Tineke M ^a   De Broe, Marc E ^a   D'Haese, Patrick C ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

cell biology and structure; chronic kidney disease; vascular calcification

Indexed keywords

CALCIUM; NANOCRYSTAL;

APOPTOSIS; ARTERY CALCIFICATION; BLOOD VESSEL CALCIFICATION; BONE REMODELING; CALCIUM BALANCE; CHRONIC KIDNEY DISEASE; CRYSTALLIZATION; CYTOLOGY; DISEASE COURSE; ENCHONDRAL OSSIFICATION; EXTRACELLULAR MATRIX; HEMODIALYSIS PATIENT; HIGH RISK POPULATION; HUMAN; MORTALITY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL REPLACEMENT THERAPY; REVIEW; SIGNAL TRANSDUCTION; SKIN NECROSIS;

EID: 79956013987     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.59     Document Type: Review

References (120)

1. Chiu YW, Adler SG, Budoff MJ et al. Coronary artery calcification and mortality in diabetic patients with proteinuria. Kidney Int 2010; 77: 1107-1114.
2. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942. (Pubitemid 34258697)
3. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740. (Pubitemid 37098542)
4. Nakamura S, Ishibashi-Ueda H, Niizuma S et al. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 2009; 4: 1892-1900.
5. Temmar M, Liabeuf S, Renard C et al. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens 2010; 28: 163-169.
6. Gross ML, Meyer HP, Ziebart H et al. Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and X-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol 2007; 2: 121-134.
7. Moe SM, O'Neill KD, Duan D et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 2002; 61: 638-647. (Pubitemid 34102607)
8. Lehto S, Niskanen L, Suhonen M et al. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulindependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996; 16: 978-983. (Pubitemid 26266896)
9. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483. (Pubitemid 30318271)
10. McCullough PA, Sandberg KR, Dumler F et al. Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol 2004; 17: 205-215. (Pubitemid 38779772)
11. Yuen D, Pierratos A, Richardson RM et al. The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant 2006; 21: 1407-1412.
12. Adeney KL, Siscovick DS, Ix JH et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 2009; 20: 381-387.
13. Noordzij M, Cranenburg EM, Engelsman LF et al. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant; e-pub ahead of print 29 September 2010.
14. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701. (Pubitemid 34158168)
15. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17.
16. Reynolds JL, Joannides AJ, Skepper JN et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867. (Pubitemid 41103395)
17. Moe SM, Reslerova M, Ketteler M et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005; 67: 2295-2304. (Pubitemid 41623389)
18. O'Neill WC, Sigrist MK, McIntyre CW. Plasma pyrophosphate and vascular calcification in chronic kidney disease. Nephrol Dial Transplant 2010; 25: 187-191.
19. Schurgers LJ, Barreto DV, Barreto FC et al. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol 2010; 5: 568-575.
20. Nakashima K, Zhou X, Kunkel G et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108: 17-29. (Pubitemid 34137009)
21. Matsubara T, Kida K, Yamaguchi A et al. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 2008; 283: 29119-29125.
22. Ducy P, Zhang R, Geoffroy V et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-754. (Pubitemid 27516177)
23. Gehron RP. The biochemistry of bone. Endocrinol Metab Clin North Am 1989; 18: 858-902.
24. Anderson HC. Matrix vesicles and calcification. Curr Rheumatol Rep 2003; 5: 222-226.
25. Caverzasio J, Bonjour JP. Characteristics and regulation of Pi transport in osteogenic cells for bone metabolism. Kidney Int 1996; 49: 975-980. (Pubitemid 26122700)
26. Anderson HC. Mechanism of mineral formation in bone. Lab Invest 1989; 60: 320-330. (Pubitemid 19095948)
27. Flavus MJ. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Am Soc Bone Miner Res, 5th edn., Washington, DC, 2003.
28. Junqueira LC, Carneiro J, Kelley RO. Basic Histology, 7th edn., Appleton & Lange: East Norwalk, Connecticut, 1996.
29. Cohen Jr MM. The new bone biology: pathologic, molecular, and clinical correlates. Am J Med Genet A 2006; 140: 2646-2706. (Pubitemid 44865095)
30. Akiyama H, Chaboissier MC, Martin JF et al. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 2002; 16: 2813-2828. (Pubitemid 35253149)
31. de Crombrugghe B, Lefebvre V, Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol 2001; 13: 721-727. (Pubitemid 33048841)
32. Colnot CI, Helms JA. A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech Dev 2001; 100: 245-250. (Pubitemid 32109333)
33. Murshed M, Harmey D, Millan JL et al. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 2005; 19: 1093-1104. (Pubitemid 40632454)
34. Chen NX, O'Neill KD, Duan D et al. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 2002; 62: 1724-1731. (Pubitemid 35286280)
35. Shanahan CM, Cary NR, Salisbury JR et al. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 100: 2168-2176.
36. Tyson KL, Reynolds JL, McNair R et al. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 2003; 23: 489-494. (Pubitemid 36337227)
37. Qiao JH, Mertens RB, Fishbein MC et al. Cartilaginous metaplasia in calcified diabetic peripheral vascular disease: morphologic evidence of enchondral ossification. Hum Pathol 2003; 34: 402-407. (Pubitemid 36535026)
38. Neven E, Dauwe S, De Broe ME et al. Endochondral bone formation is involved in media calcification in rats and in men. Kidney Int 2007; 72: 574-581. (Pubitemid 47312790)
39. Neven E, Persy V, Dauwe S et al. Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats. Arterioscler Thromb Vasc Biol 2010; 30: 1741-1750.
40. Luo G, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81. (Pubitemid 27130923)
41. Johnson K, Polewski M, van Etten D et al. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1+/+ mice. Arterioscler Thromb Vasc Biol 2005; 25: 686-691. (Pubitemid 40463854)
42. Speer MY, Yang HY, Brabb T et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 2009; 104: 733-741.
43. Bobryshev YV. Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: implications for diffuse intimal calcification. J Pathol 2005; 205: 641-650. (Pubitemid 40514838)
44. Doehring LC, Heeger C, Aherrahrou Z et al. Myeloid CD34+CD13+ precursor cells transdifferentiate into chondrocyte-like cells in atherosclerotic intimal calcification. Am J Pathol 2010; 177: 473-480.
45. Ergun S, Tilki D, Klein D. Vascular wall as a reservoir for different types of stem and progenitor cells. Antioxid Redox Signal; e-pub ahead of print 7 January 2011.
46. Farrington-Rock C, Crofts NJ, Doherty MJ et al. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004; 110: 2226-2232. (Pubitemid 39372506)
47. Doherty MJ, Ashton BA,Walsh S et al. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 1998; 13: 828-838. (Pubitemid 28224199)
48. Canfield AE, Doherty MJ, Wood AC et al. Role of pericytes in vascular calcification: a review. Z Kardiol 2000; 89(Suppl 2): 20-27.
49. Nahar NN, Missana LR, Garimella R et al. Matrix vesicles are carriers of bone morphogenetic proteins (BMPs), vascular endothelial growth factor (VEGF), and noncollagenous matrix proteins. J Bone Miner Metab 2008; 26: 514-519.
50. Tchetina E, Mwale F, Poole AR. Distinct phases of coordinated early and late gene expression in growth plate chondrocytes in relationship to cell proliferation, matrix assembly, remodeling, and cell differentiation. J Bone Miner Res 2003; 18: 844-851. (Pubitemid 37294967)
51. Tintut Y, Alfonso Z, Saini T et al. Multilineage potential of cells from the artery wall. Circulation 2003; 108: 2505-2510. (Pubitemid 37444413)
52. Day TF, Yang Y. Wnt and hedgehog signaling pathways in bone development. J Bone Joint Surg Am 2008; 90(Suppl 1): 19-24. (Pubitemid 351329116)
53. Nakashima K, de Crombrugghe B. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 2003; 19: 458-466. (Pubitemid 36930029)
54. Al-Aly Z, Shao JS, Lai CF et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr+/+ mice. Arterioscler Thromb Vasc Biol 2007; 27: 2589-2596. (Pubitemid 350158910)
55. Speer MY, McKee MD, Guldberg RE et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 2002; 196: 1047-1055. (Pubitemid 35231763)
56. Steitz SA, Speer MY, McKee MD et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 2002; 161: 2035-2046. (Pubitemid 35434850)
57. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 2302-2309. (Pubitemid 350203943)
58. Kirsch T, Nah HD, Shapiro IM et al. Regulated production of mineralization-competent matrix vesicles in hypertrophic chondrocytes. J Cell Biol 1997; 137: 1149-1160. (Pubitemid 27251049)
59. Anderson HC, Sipe JB, Hessle L et al. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 2004; 164: 841-847. (Pubitemid 38235466)
60. Roberts S, Narisawa S, Harmey D et al. Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization. J Bone Miner Res 2007; 22: 617-627. (Pubitemid 47457439)
61. Kirsch T, Harrison G, Golub EE et al. The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J Biol Chem 2000; 275: 35577-35583.
62. Chen NX, O'Neill KD, Chen X et al. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 2008; 23: 1798-1805.
63. Rattazzi M, Bennett BJ, Bea F et al. Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice: potential role of chondrocyte-like cells. Arterioscler Thromb Vasc Biol 2005; 25: 1420-1425. (Pubitemid 40923362)
64. Schlieper G, Aretz A, Verberckmoes SC et al. Ultrastructural analysis of vascular calcifications in uremia. J Am Soc Nephrol 2010; 21: 689-696.
65. Shroff RC, McNair R, Figg N et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118: 1748-1757.
66. Min H, Morony S, Sarosi I et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 2000; 192: 463-474. (Pubitemid 30666247)
67. Jeziorska M, McCollum C, Wooley DE. Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries. Virchows Arch 1998; 433: 559-565. (Pubitemid 28561189)
68. Tseng W, Graham LS, Geng Y et al. PKA-induced receptor activator of NF-kappaB ligand (RANKL) expression in vascular cells mediates osteoclastogenesis but not matrix calcification. J Biol Chem 2010; 285: 29925-29931.
69. Simpson CL, Lindley S, Eisenberg C et al. Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. Cardiovasc Pathol 2007; 16: 29-37. (Pubitemid 46049030)
70. Bas A, Lopez I, Perez J et al. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 2006; 21: 484-490.
71. Speer MY, Li X, Hiremath PG et al. Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J Cell Biochem 2010; 110: 935-947.
72. Gibson G. Active role of chondrocyte apoptosis in endochondral ossification. Microsc Res Tech 1998; 43: 191-204. (Pubitemid 28518821)
73. Son BK, Kozaki K, Iijima K et al. Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur J Pharmacol 2007; 556: 1-8. (Pubitemid 46073988)
74. Proudfoot D, Skepper JN, Hegyi L et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000; 87: 1055-1062.
75. Ewence AE, Bootman M, Roderick HL et al. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res 2008; 103: e28-e34.
76. Shroff RC, McNair R, Skepper JN et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2010; 21: 103-112.
77. Clarke MC, Littlewood TD, Figg N et al. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 2008; 102: 1529-1538.
78. Massy ZA, Ivanovski O, Nguyen-Khoa T et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 2005; 16: 109-116. (Pubitemid 43073162)
79. Verberckmoes SC, Persy V, Behets GJ et al. Uremia-related vascular calcification: more than apatite deposition. Kidney Int 2007; 71: 298-303. (Pubitemid 46227088)
80. Wada T, McKee MD, Steitz S et al. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 1999; 84: 166-178. (Pubitemid 29070112)
81. Sage AP, Lu J, Tintut Y et al. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 2011; 79: 414-422.
82. Sun Y, Zeng XR, Wenger L et al. Basic calcium phosphate crystals stimulate the endocytotic activity of cells-inhibition by anti-calcification agents. Biochem Biophys Res Commun 2003; 312: 1053-1059. (Pubitemid 37490922)
83. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006; 98: 905-912.
84. Byon CH, Javed A, Dai Q et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 2008; 283: 15319-15327.
85. Aikawa E, Nahrendorf M, Sosnovik D et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007; 115: 377-386. (Pubitemid 46148512)
86. Aikawa E, Nahrendorf M, Figueiredo JL et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007; 116: 2841-2850. (Pubitemid 350301146)
87. Levin A, Bakris GL, Molitch M et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38. (Pubitemid 44967731)
88. Razzaque MS, Sitara D, Taguchi T et al. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 2006; 20: 720-722. (Pubitemid 46671193)
89. Stubbs JR, Liu S, Tang W et al. Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 2007; 18: 2116-2124. (Pubitemid 47041077)
90. Kuro-o M, Matsumura Y, Aizawa H et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45-51. (Pubitemid 27494749)
91. Nasrallah MM, El-Shehaby AR, Salem MM et al. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 2679-2685.
92. Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011; 22: 124-136.
93. Chertow GM, Raggi P, Chasan-Taber S et al. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1489-1496. (Pubitemid 38786743)
94. Lomashvili KA, Cobbs S, Hennigar RA et al. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 2004; 15: 1392-1401. (Pubitemid 38679664)
95. Ohnishi M, Nakatani T, Lanske B et al. In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels. Circ Cardiovasc Genet 2009; 2: 583-590.
96. Demirci MS, Ozkahya M, Asci G et al. The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients. Perit Dial Int 2009; 29(Suppl 2): S15-S17.
97. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252. (Pubitemid 34754068)
98. Asmus HG, Braun J, Krause R et al. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant 2005; 20: 1653-1661. (Pubitemid 41418591)
99. Nagano N, Miyata S, Abe M et al. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int 2006; 69: 531-537. (Pubitemid 43164446)
100. London GM, Marchais SJ, Guerin AP et al. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008; 19: 1827-1835.
101. Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 2004; 66: 2293-2299. (Pubitemid 41115292)
102. Lomashvili K, Garg P, O'Neill WC. Chemical and hormonal determinants of vascular calcification in vitro. Kidney Int 2006; 69: 1464-1470.
103. Villa-Bellosta R, Millan A, Sorribas V. Role of calcium-phosphate deposition in vascular smooth muscle cell calcification. Am J Physiol Cell Physiol 2011; 300: C210-C220.
104. Kurz P, Monier-Faugere MC, Bognar B et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994; 46: 855-861. (Pubitemid 24272045)
105. Young EW, Akiba T, Albert JM et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 34-38.
106. London GM, Marty C, Marchais SJ et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004; 15: 1943-1951. (Pubitemid 38822076)
107. Suda T, Ueno Y, Fujii K et al. Vitamin D and bone. J Cell Biochem 2003; 88: 259-266. (Pubitemid 36119896)
108. Shroff R, Egerton M, Bridel M et al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 2008; 19: 1239-1246.
109. Lopez I, Guilera-Tejero E, Mendoza FJ et al. Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol. J Am Soc Nephrol 2006; 17: 795-804.
110. Ivanovski O, Nikolov IG, Joki N et al. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE+/+) mice. Atherosclerosis 2009; 205: 55-62.
111. Ishii H, Wada M, Furuya Y et al. Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia. Bone 2000; 26: 175-182. (Pubitemid 30029211)
112. Mizobuchi M, Finch JL, Martin DR et al. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int 2007; 72: 709-715. (Pubitemid 47373790)
113. Mathew S, Lund RJ, Chaudhary LR et al. Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 2008; 19: 1509-1519.
114. Oner-Iyidogan Y, Oner P, Kocak H et al. Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis. Clin Exp Med 2009; 9: 235-241.
115. Jung HH, Kim SW, Han H. Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 2006; 21: 1915-1920. (Pubitemid 43985720)
116. Krasniak A, Drozdz M, Pasowicz M et al. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant 2007; 22: 515-521. (Pubitemid 46193946)
117. Oh J, Wunsch R, Turzer M et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105. (Pubitemid 34747448)
118. Ishimura E, Okuno S, Kitatani K et al. C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries. Semin Nephrol 2004; 24: 408-412. (Pubitemid 39361043)
119. Tintut Y, Patel J, Parhami F et al. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000; 102: 2636-2642.
120. Lee HL, Woo KM, Ryoo HM et al. Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. Biochem Biophys Res Commun 2010; 391: 1087-1092.